Syndax Pharmaceuticals IncSNDX
Price (close)
$17.97
Market cap
$1.6B
P/E
—
Revenue (TTM)
$252.3M
Net income
-$220.8M
Dividend yield
—
1-year total return
19.6%
Net margin
-87.5%
Revenue growth
222.7%
Debt / equity
22.78x
What Syndax Pharmaceuticals Inc does.
No business description on file yet.
Revenue and profit, by fiscal year.
| Fiscal year | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Revenue | $1.5M | $139.7M | $0 | $0 | $23.7M | $172.4M |
| Net income | -$73.2M | $24.9M | -$149.3M | -$209.4M | -$318.8M | -$285.4M |
| Free cash flow | -$71.3M | $29.0M | -$133.7M | -$160.6M | -$274.9M | -$323.2M |
More on SNDX.
- Syndax Pharmaceuticals Inc summary
- Syndax Pharmaceuticals Inc financial statements
- Syndax Pharmaceuticals Inc key metrics
- Syndax Pharmaceuticals Inc health scores and style box
- Syndax Pharmaceuticals Inc earnings
- Syndax Pharmaceuticals Inc dividends
- Syndax Pharmaceuticals Inc valuation
- Syndax Pharmaceuticals Inc ownership and insiders
- Syndax Pharmaceuticals Inc peers
Figures from Syndax Pharmaceuticals Inc's filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.